首页 | 本学科首页   官方微博 | 高级检索  
     


Chronic neuropathic pain in spinal cord injury: Efficiency of deep brain and motor cortex stimulation therapies for neuropathic pain in spinal cord injury patients
Authors:J.-G. Prévinaire  J.P. Nguyen  B. Perrouin-Verbe  C. Fattal
Affiliation:1. Département médullaire, centre Calvé, 72, esplanade Parmentier, 62600 Berck-sur-Mer, France;2. Service de neurochirurgie, hôpital Laennec, 44035 Nantes, France;3. Service de MPR neurologique, hôpital Saint Jacques, CHU Nantes, 44093 Nantes cedex, France;4. Centre mutualiste-neurologique, Propara, 263, rue du Caducée, 34090 Montpellier, France
Abstract:ObjectivesIn spite of all the scientific advances in pharmacological research, a great number of patients cannot efficiently manage their chronic pain with conventional pharmacological treatments. Brain stimulation techniques have considerably improved these last 10 years. These techniques could be an interesting option after a rigorous selection of patients. We aim to evaluate the efficacy of brain stimulation (deep brain stimulation [DBS] and motor cortex stimulation [MCS]) within the framework of neuropathic pain management in spinal cord injury (SCI) patients and elaborate some recommendations.Material and methodThe methodology used, proposed by the French Society of Physical Medicine and Rehabilitation (SOFMER), includes a systematic review of the literature, the gathering of information regarding current clinical practices and a validation by a multidisciplinary panel of experts.ResultsDBS is more effective on nociceptive pain than deafferentation pain. For the central pain of SCI patients, the long-term efficacy of DBS is quite low (three patients out of 19, amounting to 16%). MCS seems to have an interesting potential with a long-term efficacy of 57% (four patients out of seven), with less complications than DBS.ConclusionFor central pain in SCI patients, there is no sufficient level of evidence to validate the use of DBS. There is however a low level of evidence for MCS. These results must be validated by larger comparative or controlled versus placebo clinical studies.
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号